Score Overview
Explore the 2021 public Archive ranking β
Where NeoGenomics Inc has ranked, year by year
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- NEO
2006: 71.6% Β· 2021: 22.7% Β· free through 2021 Β· longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 18.74 | β |
1 Year2025-09-29 | $ 7.77 | 141.18% |
5 Years2021-09-29 | $ 48.81 | -61.61% |
10 Years2016-09-29 | $ 7.95 | 135.76% |
20 Years2006-09-29 | $ 1.00 | 18x |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 |
|---|---|---|---|---|---|
| Price | $ 18.74 | $ 7.77 | $ 48.81 | $ 7.95 | $ 1.00 |
| Return | β | 141.18% | -61.61% | 135.76% | 18x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 766M | -$ 51M | $ 145M |
| 2025 | $ 727M | -$ 108M | $ 159M |
| 2024 | $ 660M | -$ 78M | $ 386M |
| 2023 | $ 591M | -$ 87M | $ 415M |
| 2022 | $ 509M | -$ 144M | $ 437M |
| 2021 | $ 484M | -$ 8M | $ 515M |
| 2020 | $ 444M | $ 4M | $ 296M |
| 2019 | $ 408M | $ 8M | $ 173M |
| 2018 | $ 276M | $ 2M | $ 9M |
| 2017 | $ 240M | -$ 396K | $ 12M |
| 2016 | $ 244M | -$ 6M | $ 12M |
| 2015 | $ 99M | -$ 2M | $ 23M |
| 2014 | $ 87M | $ 1M | $ 33M |
| 2013 | $ 66M | $ 2M | $ 4M |
| 2012 | $ 59M | $ 65K | $ 1M |
| 2011 | $ 43M | -$ 1M | $ 2M |
| 2010 | $ 34M | -$ 3M | $ 1M |
| 2009 | $ 29M | -$ 2M | $ 1M |
| 2008 | $ 20M | -$ 1M | $ 468.17K |
| 2007 | $ 11M | -$ 3M | $ 210.57K |
| 2006 | $ 6M | -$ 130K | $ 126.27K |
| 2005 | $ 1M | -$ 997K | $ 10.94K |
| 2004 | $ 558.07K | -$ 819K | $ 112.55K |
| 2003 | $ 369.97K | -$ 536K | $ 25.05K |
| 2002 | $ 93.49K | -$ 590.52K | |
| 2001 | -$ 8M | $ 77.22K | |
| 2000 | $ 252.4K | -$ 970K | $ 186.00 |

NeoGenomics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 444M to $ 727M and net income went from $ 4M to -$ 108M. Revenue increased in every one of those 5 years; net income in 3.
Across NeoGenomics Inc's full reported history, from 2000 to 2025, revenue grew from $ 252.4K to $ 727M and net income went from -$ 970K to -$ 108M. Revenue increased in 96% of the years measured; net income in 50%.
NeoGenomics Inc currently holds a 20-year HDB Score of 4.2 out of 10. How the HDB Score is calculated.
Membership
Continue NEOβs history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio




